Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum

Back

ESC Professional Premium Access

Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum

Session: Epidemiology and outcomes

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor G. Heitzinger (Vienna, AT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Gregor Heitzinger

Medical University of Vienna, Vienna (Austria)

0 follower

7 more presentations in this session

The prognostic association of atrial fibrillation on heart failure hospitalizations after acute myocardial infarction

Speaker: Doctor A. Achanta (Boston, US)

Incorporating hypochloremia provides additive prognostic information in hospitalized patients with heart failure

Speaker: Doctor K. Misumi (Utsunomiya, JP)

Comparative effectiveness of GDMT in the prevention of HF morbidity and death among patients with HFrEF in a U.S. database

Speaker: Doctor L. Bash (Whitehouse Station, US) Doctor A. Stevenson (Chatham, US)

Change in incidence of ischemic stroke and mortality among patients with atrial fibrillation over a period of 30 years, a nationwide, register-based cohort study

Speaker: Doctor C. Basic (Gothenburg, SE)

Long-term prognostic significance modified body mass index in patients with decompensated acute heart failure: Insight from the OPAR study

Speaker: Doctor Y. Chang (Osaka, JP)

Access the full session

Epidemiology and outcomes

Speakers: Doctor G. Heitzinger, Doctor A. Achanta, Doctor K. Misumi, Doctor L. Bash, Doctor A. Stevenson...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources